_PRIVATE_LIMITED.webp)
Terramera Biosciences (India) Profile
Key Indicators
- Authorised Capital ₹ 3.20 M
- Paid Up Capital ₹ 3.11 M
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 309.70%
- Profit Growth 596.06%
- Ebitda 141.13%
- Net Worth 21.77%
- Total Assets 143.77%
About Terramera Biosciences (India)
Terramera Biosciences (India) Private Limited (TBIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 29 August 2012 and has a history of 12 years and five months. Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.20 M and a paid-up capital of Rs 3.11 M, as per Ministry of Corporate Affairs (MCA) records.
Maxwell Samuel, Matthew Dahabieh, and Nathanael Kelly serve as directors at the Company.
Company Details
- Location
Tiruvallur, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U40104TN2012FTC087406
- Company No.
087406
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
29 Aug 2012
- Date of AGM
29 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Terramera Biosciences (India)?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maxwell Samuel  | Director | 25-Sep-2014 | Current |
| Matthew Dahabieh | Director | 29-Aug-2024 | Current |
| Nathanael Kelly | Director | 29-Aug-2024 | Current |
Financial Performance of Terramera Biosciences (India).
Terramera Biosciences (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 309.7% increase. The company also saw a substantial improvement in profitability, with a 596.06% increase in profit. The company's net worth Soared by an impressive increase of 21.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Terramera Biosciences (India)?
In 2021, Terramera Biosciences (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Terramera Biosciences (India)?
Terramera Biosciences (India) has a workforce of 16 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Terramera Biosciences (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Terramera Biosciences (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
